MetLife Investment Management’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

MetLife Investment Management’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8,207	Closed	-$83.6K	–	2901
2023 Q3	$83.6K	Buy	+8,207	New	+$62.5K	﹤0.01%	2670

MetLife Investment Management's THRN Position: Q4 2023 in Review

MetLife Investment Management sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 8,207 shares — an estimated $83.6K sold.

MetLife Investment Management first reported a position in THRN in Q3 2023 and held it in 1 quarter. The position peaked at $83.6K in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

MetLife Investment Management reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
MetLife Investment Management sold 8,207 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $83.6K.
MetLife Investment Management first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
MetLife Investment Management's Thorne Healthtech, Inc. Common Stock position peaked at $83.6K in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.